Literature DB >> 11086028

Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis.

R F Guo1, M Huber-Lang, X Wang, V Sarma, V A Padgaonkar, R A Craig, N C Riedemann, S D McClintock, T Hlaing, M M Shi, P A Ward.   

Abstract

Multiorgan apoptosis occurs during sepsis. Following cecal ligation and puncture (CLP) in rats, thymocytes underwent apoptosis in a time-dependent manner. C5a blockade dramatically reduced thymocyte apoptosis as measured by thymic weight, binding of annexin V to thymocytes, and laddering of thymocyte DNA. When C5a was generated in vivo by infusion of purified cobra venom factor (CVF), thymocyte apoptosis was significantly increased. Similar results were found when CVF was injected in vivo during the early stages of CLP. In animals 12 hours after induction of CLP, there was an increase in the activities of caspase-3, -6, and -9, but not caspase-1 and -8. Cytosolic cytochrome c levels increased by twofold, whereas mitochondrial levels showed a 50% decrease. Western blot analysis revealed that the content of Bcl-X(L) (but not of Bcl-2, BAX, Bad, and Bim) significantly decreased in thymocytes after CLP. C5a blockade in the sepsis model almost completely inhibited caspase-3, -6, and -9 activation, significantly preserved cytochrome c in the mitochondrial fraction, and restored Bcl-X(L) expression. These data suggest that systemic activation of complement induces C5a-dependent apoptosis of thymocytes and that the blockade of C5a during sepsis rescues thymocytes from apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086028      PMCID: PMC381438          DOI: 10.1172/JCI10793

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

1.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta.

Authors:  T Nakagawa; H Zhu; N Morishima; E Li; J Xu; B A Yankner; J Yuan
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

2.  Caspases -2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis.

Authors:  K W Tinsley; S L Cheng; T G Buchman; K C Chang; J J Hui; P E Swanson; I E Karl; R S Hotchkiss
Journal:  Shock       Date:  2000-01       Impact factor: 3.454

Review 3.  Caspases: enemies within.

Authors:  N A Thornberry; Y Lazebnik
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 4.  Caspases: key mediators of apoptosis.

Authors:  N A Thornberry
Journal:  Chem Biol       Date:  1998-05

Review 5.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

6.  Prevention of lymphocyte cell death in sepsis improves survival in mice.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; K C Chang; J P Cobb; T G Buchman; S J Korsmeyer; I E Karl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 7.  Involvement and dual effects of nitric oxide in septic shock.

Authors:  P P Wolkow
Journal:  Inflamm Res       Date:  1998-04       Impact factor: 4.575

8.  Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9.

Authors:  K Kuida; T F Haydar; C Y Kuan; Y Gu; C Taya; H Karasuyama; M S Su; P Rakic; R A Flavell
Journal:  Cell       Date:  1998-08-07       Impact factor: 41.582

9.  Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.

Authors:  I Farkas; L Baranyi; Z S Liposits; T Yamamoto; H Okada
Journal:  Neuroscience       Date:  1998-10       Impact factor: 3.590

10.  An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis.

Authors:  T Hettmann; J DiDonato; M Karin; J M Leiden
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  42 in total

1.  Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.

Authors:  Zoltán H Németh; Balázs Csóka; Jeanette Wilmanski; Dazhong Xu; Qi Lu; Catherine Ledent; Edwin A Deitch; Pál Pacher; Zoltán Spolarics; György Haskó
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

2.  Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis.

Authors:  Ruonan Xu; Fang Lin; Chunmei Bao; Huihuang Huang; Chengcheng Ji; Siyu Wang; Lei Jin; Lijian Sun; Ke Li; Zheng Zhang; Fu-Sheng Wang
Journal:  Cell Mol Immunol       Date:  2015-03-02       Impact factor: 11.530

Review 3.  Current and future concepts of abdominal sepsis.

Authors:  Klaus Emmanuel; Heike Weighardt; Holger Bartels; Jorg-Rudiger Siewert; Bernhard Holzmann
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

Review 4.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 5.  Sepsis, apoptosis and complement.

Authors:  P A Ward
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

6.  Functions of the complement components C3 and C5 during sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; Peter A Ward
Journal:  FASEB J       Date:  2008-06-27       Impact factor: 5.191

7.  Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.

Authors:  György Haskó; Balázs Csóka; Balázs Koscsó; Rachna Chandra; Pál Pacher; Linda F Thompson; Edwin A Deitch; Zoltán Spolarics; László Virág; Pál Gergely; Rolando H Rolandelli; Zoltán H Németh
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

Review 8.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

10.  VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.

Authors:  Peter Weber; Ping Wang; Stephane Maddens; Paul Sh Wang; Rongqian Wu; Michael Miksa; Weifeng Dong; Michael Mortimore; Julian M C Golec; Peter Charlton
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.